Rankings
▼
Calendar
MLTX Q2 2023 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena
MLTX
MoonLake Immunotherapeutics
$1B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$10M
EPS (Diluted)
$-0.23
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$507M
Total Liabilities
$8M
Stockholders' Equity
$490M
Cash & Equivalents
$502M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$13M
-$18M
+25.3%
Net Income
-$10M
-$12M
+16.3%
Revenue Segments
License
$300M
100%
← FY 2023
All Quarters
Q3 2023 →